This guideline aims to provide specific, patient-focused recommendations on management and care of people with suspected or confirmed COVID-19. With the exception of chemoprophylaxis for the prevention of infection in people exposed to COVID-19, the guideline does not include other interventions used in ...
Diagnóstico Clínico/diagnóstico,
Betacoronavirus/efectos de los fármacos,
Infecciones por Coronavirus/diagnóstico,
Neumonía Viral/diagnóstico,
Hipoxia/diagnóstico,
Gravedad del Paciente,
Infecciones por Coronavirus/tratamiento farmacológico,
Neumonía Viral/tratamiento farmacológico,
Dexametasona/uso terapéutico,
Lactancia Materna,
Antivirales/uso terapéutico,
Hidroxicloroquina/uso terapéutico,
Colchicina/uso terapéutico,
Plasma/inmunología,
Darunavir/uso terapéutico,
Interferones/uso terapéutico,
Práctica Clínica Basada en la Evidencia/métodos
La finalidad de esta guía es establecer un referente nacional para orientar la toma de decisiones clínicas basadas en recomendaciones sustentadas en la mejor evidencia disponible. Esta guía pone a disposición del personal del primer, segundo y tercer nivel de atención las recomendaciones basadas en ...
La finalidad de esta guía es establecer un referente nacional para orientar la toma de decisiones clínicas basadas en recomendaciones sustentadas en la mejor evidencia disponible. Esta guía pone a disposición del personal del primer, segundo y tercer niveles de atención las recomendaciones basadas e...
The World Health Organization’s comprehensive antenatal care (ANC) guideline WHO recommendations on antenatal care for a positive pregnancy experience was first published in 2016 with the objective of improving the quality of routine health care that all women and adolescent girls receive during pregna...
The primary goal of this recommendation is to improve the quality of care and outcomes for pregnant women and women intending to become pregnant, particularly those related to prevention of pre-eclampsia,
eclampsia and resulting complications. This recommendation may be of interest to professional societ...
This guideline provides global, evidence-informed recommendations on the use of indicators for assessing a population’s iron status and application of the use of ferritin concentrations for monitoring and evaluating iron interventions. his guideline aims to help WHO Member States and their partners to ...
WHO published interim guidelines on the prevention of sexual transmission of Zika virus in September 2016, based on a limited amount of evidence under an emergency process during a public health emergency of international concern (PHEIC). The body of evidence has grown considerably since then, and WHO ex...
Since 2007, the guideline development process within the World Health Organization (WHO) has
been overseen by the WHO Guidelines Review Committee (GRC), which follows internationally
recognized standards such as the GRADE (Grading of Recommendations Assessment, Development
and Evaluation) approach, to su...
The political declaration at the first United Nations (UN) high-level meeting on tuberculosis (TB) held
on 26 September 2018 included commitments by Member States to four new global targets.3
One of
these targets is to diagnose and treat 40 million people with TB in the 5-year period 2018–2022. The
ap...
This updated recommendation is relevant to all pregnant women and adolescent girls receiving comprehensive antenatal care (ANC) in any healthcare facility or community-based setting, and to their unborn fetuses and newborns. The question was prioritized during the ANC guideline development process. In 20...
